Pascual, MB, Zapata-Huizi, JJ, Ramos, D, Francesqui, J, Alsina-Restoy, X, Hernández-González, F, Sellares, J. Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 46(06)DOI:10.1055/a-2741-2030. PMID:41213628. IF:2.700(Q2/5D).

Tsuboi, M, Wakelee, H, Spicer, JD, Gao, S, Liberman, M, Kato, T, Chen, KN, Dooms, C, Majem, M, Martinengo, GL, Bylicki, O, Abreu, DR, Halmos, B, Jones, DR, Chaft, J, Reck, M, Jense, E, Keller, SM, Samkari, A, Garassino, MC. Perioperative pembrolizumab in early-stage non-small-cell lung cancer (NSCLC): 5-year follow-up from the KEYNOTE-671 global study and Asian subgroup. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.10.607. PMID:. IF:65.400(Q1/1D).

Alós, DG, Sanchez, S, Dominguez, SR, Magnano, L, Barca, EG, Vicente, FD, Iacoboni, G, Manso, RG, Losada, CM, Huerga, S, Baumann, T, Izquierdo, AR, Bacelar, AG, Santaella, MP, Prieto, PG, De Villambrosia, SG, Bastos-Oreiro, M, Hernandez, AC, De Miguel, LB, Abellan, PF, Sturla, AL, Vidaller, PJP, Amutio, E, Toimil, FS, Pra, AM, Mico, M, De La Mano, EP, De La Cruz, B, Browne, S, Landwehr, M, Hernandez, I, Andreu, R, De La Cruz, J, Ubieto, AJ. Impact of EBV status on the characteristics and prognosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients: Long-term experience from the GELTAMO group. BLOOD. 2025; 146DOI:10.1182/blood-2025-472. PMID:. IF:23.100(Q1/1D).

Moya, TA, Gay, MQS, Pasic, I, Gonzalez, MB, Gómez, MA, Salinas, AS, Camacho, JS, Alvaro, VI, Abdallah-Lefdil, Z, Navascues, JC, Gambarte, LP, Fernandez-Luis, S, Vega, L, Villar, S, Murillo, PB, Esquirol, A, Garcia, II, Mussetti, A, Lavilla-Rubira, E, Lopez, J, Filafferro, S, Balsalobre, P, Miguel, LBD, Michelis, F, Viswabandya, A, Mattsson, J, Alibhai, S, Rovira, M, Kim, D, Balari, AS, Kumar, R. Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients. BLOOD. 2025; 146DOI:10.1182/blood-2025-2652. PMID:. IF:23.100(Q1/1D).

Kroeger, N, Sanz, J, Stelljes, M, Martino, R, Rambaldi, A, Kwon, M, Sanchez-Guijo, F, Markova, M, Bondarenko, S, Eder, M, Heuser, M, Solano, C, Bonifazi, F, Wohlfarth, P, Massoud, R, Ayuk, F, Clausen, J, Choi, G, Greinix, H, Chiusolo, P, Patriarca, F, Gagelmann, N, Busca, A, Bug, G, Schroeder, T, Bethge, W, Glöckner, A, Hoelzer, D, Zey, S, Buchner, H, Wolschke, C. Matched unrelated vs. Haploidentical donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis-a randomized prospective european trial. BLOOD. 2025; 146DOI:10.1182/blood-2025-171. PMID:. IF:23.100(Q1/1D).

Westin, J, Chavez, J, Schuster, SJ, Vucinic, V, Young, PA, Johnson, PC, Bramanti, S, Rambaldi, A, Meijide, JB, Kato, K, Sancho, JM, Kwon, M, Solano, C, Fleming, S, Dahiya, S, Garcia-Sancho, AM, Ramos, PM, Pearson, D, Diallo, S, Zia, A, Segura, E, Masood, A, Barba, P. Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results. BLOOD. 2025; 146DOI:10.1182/blood-2025-670. PMID:. IF:23.100(Q1/1D).

Barba, P, Rambaldi, A, Boissel, N, Doki, N, Blaise, D, Ciceri, F, Meijide, JB, Kwon, M, Fleming, S, Goñi, CB, Teshima, T, Kato, K, Balsat, M, Jaeger, U, Shune, L, Ramos, PM, Pearson, D, Corcoran, J, Zia, A, Foster, M, Masood, A, Dickinson, M. Phase 1 evaluation of the safety and efficacy of rapcabtagene autoleucel (YTB323) in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). BLOOD. 2025; 146DOI:10.1182/blood-2025-811. PMID:. IF:23.100(Q1/1D).

Hinson, SR, Gupta, P, Paramasivan, NK, Dyck, PJB, Lennon, VA, Lachance, DH, Knight, AM, Rezk, M, Karsten, C, LaFrance-Corey, RG, Staff, NP, Hrstka, SC, Wu, JC, Klein, CJ, Zekeridou, A, Mckeon, A, Pittock, SJ, Lleixà, C, Querol, L, Dasari, S, Mills, JR, Dubey, D. Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathy. EBioMedicine. 2025; 122DOI:10.1016/j.ebiom.2025.106053. PMID:41337934. IF:10.800(Q1/1D).